DK97784A - Dna-segment - Google Patents

Dna-segment Download PDF

Info

Publication number
DK97784A
DK97784A DK97784A DK97784A DK97784A DK 97784 A DK97784 A DK 97784A DK 97784 A DK97784 A DK 97784A DK 97784 A DK97784 A DK 97784A DK 97784 A DK97784 A DK 97784A
Authority
DK
Denmark
Prior art keywords
gene
segment
dna
vector
yeast
Prior art date
Application number
DK97784A
Other languages
Danish (da)
English (en)
Other versions
DK97784D0 (da
Inventor
David Botstein
Ronald Wayne Davis
Gerald Ralph Fink
Alison Taunton-Rigby
Robert Gentry Knowlton
Jen-I Mao
Donald Taylor Moir
Christopher Godfrey Goff
Original Assignee
Collaborative Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23869556&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK97784(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Collaborative Res Inc filed Critical Collaborative Res Inc
Publication of DK97784D0 publication Critical patent/DK97784D0/da
Publication of DK97784A publication Critical patent/DK97784A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Road Signs Or Road Markings (AREA)
DK97784A 1983-02-28 1984-02-24 Dna-segment DK97784A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/470,911 US4661454A (en) 1983-02-28 1983-02-28 GAL1 yeast promoter linked to non galactokinase gene

Publications (2)

Publication Number Publication Date
DK97784D0 DK97784D0 (da) 1984-02-24
DK97784A true DK97784A (da) 1984-08-29

Family

ID=23869556

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97784A DK97784A (da) 1983-02-28 1984-02-24 Dna-segment

Country Status (8)

Country Link
US (1) US4661454A (de)
EP (1) EP0123811B1 (de)
JP (1) JPS6058077A (de)
AT (1) ATE64416T1 (de)
CA (1) CA1283373C (de)
DE (1) DE3484689D1 (de)
DK (1) DK97784A (de)
GB (1) GB2137208B (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0128743A3 (de) * 1983-06-07 1985-12-27 Genex Corporation Expression von Fremdgenen in Hefe
EP0132309A3 (de) * 1983-06-27 1985-12-27 The Board Of Trustees Of The Leland Stanford Junior University Regulierbares eukaryotisches Promotorelement
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
DE3578435D1 (de) * 1984-12-06 1990-08-02 Labofina Sa Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
US5037806A (en) * 1985-02-22 1991-08-06 Monsanto Company Biologically active method using somatotropins
US4861868A (en) * 1985-02-22 1989-08-29 Monsanto Company Production of proteins in procaryotes
DE3689899T2 (de) * 1985-04-08 1994-09-15 Amgen Verfahren und hybridpromotor zur steuerung der exogenen gentranskription.
DE3689020T2 (de) * 1985-08-02 1994-04-07 Merck & Co Inc Fermentationsausbeute an exprimiertem Protein.
JPH0668B2 (ja) * 1985-08-30 1994-01-05 財団法人化学及血清療法研究所 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
US5002876A (en) * 1986-09-22 1991-03-26 Phillips Petroleum Company Yeast production of human tumor necrosis factor
US5013652A (en) * 1986-10-14 1991-05-07 Genex Corporation Composite yeast vectors
US5882884A (en) * 1987-06-19 1999-03-16 Lucky Biotech Corporation Expression of proteinaceous sweeteners in yeast
US5487990A (en) * 1988-07-01 1996-01-30 The General Hospital Corporation Glucose-regulated promoter of yeast acetyl-CoA hydrolase
US5057419A (en) * 1988-09-22 1991-10-15 Rutgers University Genetically engineered plasmid and organisms for the production of specialized oils
US5187079A (en) * 1988-12-21 1993-02-16 The Research Foundation Of State University Of New York Glucose-repressible gene for the regulated expression of proteins and expression vector therefor
AU7586991A (en) * 1990-03-21 1991-10-21 Board Of Regents, The University Of Texas System Yeast expression vectors
DK0548165T3 (da) 1990-09-13 2001-07-16 Univ Duke Ekspression af G-proteinkoblede receptorer i gær
JPH04287683A (ja) * 1991-03-14 1992-10-13 Ajinomoto Co Inc 酵母変異株およびそれを利用するペプチドまたは蛋白質　　　　　　　　　　　等の製造方法
GB9226065D0 (en) * 1992-12-14 1993-02-10 Ici Plc Peptides
DE4303744A1 (de) * 1993-02-09 1994-08-11 Univ Autonoma De Nuevo Leon Mo Hundewachstumshormon
DE19534120A1 (de) 1995-09-14 1997-03-20 Hoechst Ag Verwendung von Cytohesin-PH-Peptiden zur Beeinflußung der Adhäsionsfähigkeit von Integrinen
WO1997024457A1 (en) 1995-12-29 1997-07-10 Guilford Pharmaceuticals Inc. Method and kit for detection of multiple protein interactions
US5886151A (en) 1996-05-03 1999-03-23 Regents Of The University Of Minnesota Candida albicans integrin-like protein
ES2258788T3 (es) 1996-10-16 2006-09-01 Zymogenetics, Inc. Homologos del factor de crecimiento de fibroblastos.
US6265186B1 (en) 1997-04-11 2001-07-24 Dsm N.V. Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
GB9726897D0 (en) * 1997-12-20 1998-02-18 Zeneca Ltd Process
EA014417B1 (ru) 1998-09-23 2010-12-30 Займодженетикс, Инк. Экспрессирующий вектор, содержащий полинуклеотид, кодирующий зрелый полипептид zalpha11 рецептора цитокина человека класса i или его функциональные компоненты, культивируемые клетки, содержащие экспрессирующий вектор, способ получения зрелого полипептида zalpha11 или его функциональных компонентов, полипептид, полученный данным способом, антитело, которое связывается с полипептидом, и полинуклеотид, кодирующий полипептид
EP1988102B1 (de) 1998-12-07 2013-08-21 ZymoGenetics, Inc. Wachstumsfaktor homolog ZVEGF3
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
CN101518648A (zh) 1999-01-07 2009-09-02 津莫吉尼蒂克斯公司 可溶性受体br43×2和应用方法
CN1927883B (zh) 1999-03-09 2011-09-21 津莫吉尼蒂克斯公司 新的细胞因子zalpha11配体
DK1860188T3 (da) 1999-07-07 2011-06-27 Zymogenetics Inc Human cytokin-receptor
JP2003524415A (ja) 1999-12-23 2003-08-19 ザイモジェネティクス，インコーポレイティド サイトカインｚｃｙｔｏ１８
WO2001087933A2 (en) 2000-05-11 2001-11-22 Zymogenetics, Inc. Zsig33-like peptides
PT1325115T (pt) 2000-06-26 2016-09-28 Zymogenetics Inc Recetor de citocina zcytor17
US6927040B2 (en) 2000-06-30 2005-08-09 Zymogenetics, Inc. Interferon-like protein Zcyto21
EP1736545A3 (de) 2000-08-08 2007-03-28 ZymoGenetics, Inc. Lösliche Zcyctor 11 Cytokinrezeptoren
CA2433534A1 (en) 2000-12-28 2002-07-11 Toyota Jidosha Kabushiki Kaisha Process for producing prenyl alcohol
JP2004533997A (ja) 2001-02-20 2004-11-11 ザイモジェネティクス，インコーポレイティド Ｂｃｍａ及びｔａｃｉの両者を結合する抗体
EA007275B1 (ru) 2001-05-24 2006-08-25 Займодженетикс, Инк. Слитые белки taci-иммуноглобулина
ATE444363T1 (de) 2001-11-05 2009-10-15 Zymogenetics Inc Il-21-antagonisten
SI2230299T1 (sl) 2002-01-18 2012-07-31 Zymogenetics Inc Nov citokinski zcytor ligand
EP2338910B1 (de) 2002-01-18 2015-07-08 ZymoGenetics, Inc. Zytokinrezeptor Zyctor17-Multimere
WO2003089603A2 (en) 2002-04-19 2003-10-30 Zymogenetics, Inc. Cytokine receptor
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US7785871B2 (en) * 2002-10-09 2010-08-31 Intrexon Corporation DNA cloning vector plasmids and methods for their use
US20080050808A1 (en) * 2002-10-09 2008-02-28 Reed Thomas D DNA modular cloning vector plasmids and methods for their use
CA2534907C (en) 2003-08-07 2014-04-29 Zymogenetics, Inc. Homogeneous preparations of il-28 and il-29
CN1283792C (zh) * 2003-11-14 2006-11-08 余伟明 生物大分子组分相分离法
CA2558811A1 (en) 2004-03-08 2005-09-22 Zymogenetics, Inc. Dimeric fusion proteins and materials and methods for producing them
EP2484772B1 (de) 2004-05-18 2016-08-17 Intrexon Corporation Verfahren zur dynamischen Vektorassemblierung zur DNA-Klonierung von Vektorplasmiden
JP2008508310A (ja) 2004-07-29 2008-03-21 ザイモジェネティクス， インコーポレイテッド がんおよび自己免疫障害を治療するためのｉｌ−２８およびｉｌ−２９の使用法
CA2834275A1 (en) 2004-08-02 2006-02-09 Basf Plant Science Gmbh Method for isolation of transcription termination sequences
JP2008532931A (ja) 2005-02-08 2008-08-21 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２０、抗ｉｌ−２２および抗ｉｌ−２２ｒａ抗体ならびに結合パートナー、ならびに炎症における使用法
EP3683230A1 (de) 2005-05-12 2020-07-22 ZymoGenetics, Inc. Zusammensetzungen und verfahren zur modulation von immunsystemreaktionen
US8808696B2 (en) 2005-08-09 2014-08-19 Ares Trading S.A. Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
CN101262876A (zh) * 2005-08-09 2008-09-10 酶遗传学股份有限公司 用taci-ig融合分子治疗b细胞恶性肿瘤的方法
US8153598B2 (en) * 2005-10-19 2012-04-10 Intrexon Corporation PKD ligands and polynucleotides encoding PKD ligands
EA015342B1 (ru) * 2006-05-15 2011-06-30 Арес Трейдинг С.А. Способы лечения аутоиммунных заболеваний с использованием слитой молекулы taci-ig
EP2164863A4 (de) 2007-06-15 2010-07-28 Univ Arkansas Verfahren zur verabreichung von molekülen an zellen unter verwendung einer rizin-untereinheit und damit in zusammenhang stehende zusammensetzungen
EP3753947A1 (de) 2007-09-14 2020-12-23 Adimab, LLC Synthetische antikörperbibliotheken mit rationalem design und verwendungen davon
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
KR101700711B1 (ko) 2007-11-21 2017-01-31 로스킬드 유니베르시테트 얼음-결합 활성을 포함하는 폴리펩티드
EP2231702A1 (de) * 2007-12-21 2010-09-29 Ifxa A/s Proteasehemmer
CA2713055C (en) * 2008-01-25 2018-03-13 Aarhus Universitet Selective exosite inhibition of papp-a activity against igfbp-4
EP2274008B1 (de) 2008-03-27 2014-02-26 ZymoGenetics, Inc. Zusammensetzungen und verfahren zur hemmung von pdgfrbeta und vegf-a
WO2009158696A1 (en) 2008-06-27 2009-12-30 Zymogenetics, Inc. SOLUBLE HYBRID Fcγ RECEPTORS AND RELATED METHODS
CA2802017A1 (en) 2010-06-09 2011-12-15 Zymogenetics, Inc. Dimeric vstm3 fusion proteins and related compositions and methods
AU2013214771B2 (en) 2012-02-01 2017-09-07 Synthetic Genomics, Inc. Materials and methods for the synthesis of error-minimized nucleic acid molecules
WO2014202089A2 (en) 2013-06-18 2014-12-24 Roskilde Universitet Variants of anti-freeze polypeptides
CN106318942B (zh) * 2015-06-29 2018-12-25 中国科学院大连化学物理研究所 一种半乳糖激酶启动子和终止子及其应用
CN106318943B (zh) * 2015-06-29 2019-03-05 中国科学院大连化学物理研究所 半乳糖激酶启动子和终止子及其应用
KR102440820B1 (ko) 2015-09-08 2022-09-05 테리피온, 인크. ApoA-1 융합 폴리펩티드 및 관련 조성물 및 방법
WO2018136163A2 (en) 2016-12-09 2018-07-26 Theripion, Inc. Tandem apoa-1 fusion polypeptides
EP3655439A1 (de) 2017-07-20 2020-05-27 Aptevo Research and Development LLC An 5t4 und 4-1bb bindende antigenbindende proteine und zugehörige zusammensetzungen und verfahren
RU2756100C1 (ru) 2017-12-20 2021-09-28 Харбор Байомед (Шанхай) Ко., Лтд Антитела, связывающие ctla-4, и их применение
CA3082769A1 (en) 2017-12-27 2019-07-04 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
US10150801B1 (en) 2017-12-27 2018-12-11 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
WO2021040610A1 (en) 2019-08-26 2021-03-04 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
US10675332B1 (en) 2019-08-26 2020-06-09 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
CA3182917A1 (en) 2020-06-22 2021-12-30 Ya-Huei Chen Recombinant polypeptides and combinations for use in the treatment of cancer
AU2022224584A1 (en) 2021-02-19 2023-09-21 Theripion, Inc. Paraoxonase fusion polypeptides and related compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443539A (en) * 1980-02-05 1984-04-17 The Upjohn Company Process for preparing bovine growth hormone
US4666847A (en) * 1981-01-16 1987-05-19 Collaborative Research, Inc. Recombinant DNA means and method
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
EP0128743A3 (de) * 1983-06-07 1985-12-27 Genex Corporation Expression von Fremdgenen in Hefe
EP0132309A3 (de) * 1983-06-27 1985-12-27 The Board Of Trustees Of The Leland Stanford Junior University Regulierbares eukaryotisches Promotorelement

Also Published As

Publication number Publication date
DE3484689D1 (de) 1991-07-18
EP0123811B1 (de) 1991-06-12
JPS6058077A (ja) 1985-04-04
EP0123811A3 (en) 1986-03-26
GB8405129D0 (en) 1984-04-04
GB2137208B (en) 1987-05-13
ATE64416T1 (de) 1991-06-15
DK97784D0 (da) 1984-02-24
EP0123811A2 (de) 1984-11-07
CA1283373C (en) 1991-04-23
GB2137208A (en) 1984-10-03
US4661454A (en) 1987-04-28

Similar Documents

Publication Publication Date Title
DK97784D0 (da) Dna-segment
ATE103333T1 (de) Hohe proteinsyntheserate in hefe.
DK0378382T3 (da) Rekombinant DNA-fremgangsmåde og værtsceller
KR880014110A (ko) 인체 프로아포지방단백질 a-i의 발현
DK101385A (da) Molekylaer kloning og ekspression i industrielle mikroorganismearter
ATE27000T1 (de) Expression von polypeptiden in hefen.
KR920012442A (ko) 피치아 파스토리스 산성 인산효소 유전자의 dna 단편 및 이를 사용하는 방법
ES8602138A1 (es) Metodo de controlar la expresion de un gen que codifica una proteinaheterologa deseada.
RU94030817A (ru) Днк, белок,вектор, клетка, способ получения продукта
Huttner et al. DNA-mediated gene transfer without carrier DNA.
PT83968A (de) Verfahren zur verbesserung des expression von eukaryontenprotein
EP0111814A3 (de) Klonierung und Expression von nucleotiden Sequenzen die für Rinderwachstumshormon kodieren
KR940002352A (ko) 디(d)-아미노산 옥시다제 생산성 형질전환체
Yamaguchi et al. Chick embryo DNA polymerase alpha. Polypeptide components and their microheterogeneity.
Lübke et al. Analysis and optimization of recombinant protein production in Escherichia coli using the inducible pho A promoter of the E. coli alkaline phosphatase
ATE122097T1 (de) Expressionsvektor und verfahren zur regulierbaren herstellung von proteinen in eukaryonten.
DE3688549T2 (de) Verfahren zur expression von genen in hefe, dns-fragmente und plasmide die letztere fragmente enthalten und zur durchfuehrung des verfahrens verwendet werden.
ATE107358T1 (de) System der induzierbaren positiven regulation zur verwendung für die herstellung von heterologen proteinen.
Szponarski et al. Identification of 14 kDa auxin‐binding proteins in a tobacco plasma membrane subfraction responsive to auxin
IT1236844B (it) Clonaggio del gene regolabile nmt1 di schizosaccharomyces pombe e impiego delle sequenze di controllo della regolazione della trascrizione di tale gene per l'espressione regolabile di geni eterologhi
MX9702889A (es) Mejoramiento de un vector de expresion para la produccion de proteinas recombinantes.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment